What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

Open

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Factsheet

Open

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Open

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Open

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Open

COVID-19 “Round 2” – Findings & way forward (Kearney)

22 June 2020

Report

Open

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Open

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Open

Quotes from 3rd VAM conference

3 June 2020

Quote

Read more

Subscribe to our newsletter